Skip Navigation

British Journal of Anaesthesia 2009 103(1):133-134; doi:10.1093/bja/aep152
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow E-Letters: Submit a response to the article
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by White, S. M.
Right arrow Articles by Ghosh, S.
PubMed
Right arrow PubMed Citation
Right arrow Articles by White, S. M.
Right arrow Articles by Ghosh, S.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


© The Author [2009]. Published by Oxford University Press on behalf of The Board of Directors of the British Journal of Anaesthesia. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournal.org

Bupivacaine chondrotoxicity

S. M. White* and R. Turner

Sussex, UK

* E-mail: stuart.white@bsuh.nhs.uk

The first 10% of the full text of this article appears below.

Editor—We commend Webb and Ghosh1 for their editorial reviewing the growing evidence for the chondrotoxicity of intra-articular bupivacaine. We would like to add three further points for your readers' consideration. First, neither magnesium nor bupivacaine is licensed for intra-articular use, although bupivacaine has a good safety record given by this route. . . . [Full Text of this Article]

A. F. McNaught* and C. McCartney

Toronto, Canada

* E-mail: andrew.mcnaught@gmail.com

S. T. Webb* and S. Ghosh

Cambridge, UK

* E-mail: stephen.webb@papworth.nhs.uk


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?